The role of angiogenic growth factors in the immune microenvironment of glioma

被引：9
作者：
Ge, Zhengmao [1 ]
Zhang, Qi [1 ]
Lin, Wei [1 ]
Jiang, Xiaofan [1 ]
Zhang, Yanyu [1 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
angiogenic growth factor; immune cell; glioma; immune modulation; tumor microenvironment; TUMOR-ASSOCIATED MACROPHAGES; RECEPTOR TYROSINE KINASES; CD8(+) T-CELLS; DENDRITIC CELLS; LYMPHOCYTE INFILTRATION; DIFFERENTIAL EXPRESSION; FACTOR-BETA; STEM-CELLS; PDGFR-BETA; GLIOBLASTOMA;
D O I：
10.3389/fonc.2023.1254694
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Angiogenic growth factors (AGFs) are a class of secreted cytokines related to angiogenesis that mainly include vascular endothelial growth factors (VEGFs), stromal-derived factor-1 (SDF-1), platelet-derived growth factors (PDGFs), fibroblast growth factors (FGFs), transforming growth factor-beta (TGF-& beta;) and angiopoietins (ANGs). Accumulating evidence indicates that the role of AGFs is not only limited to tumor angiogenesis but also participating in tumor progression by other mechanisms that go beyond their angiogenic role. AGFs were shown to be upregulated in the glioma microenvironment characterized by extensive angiogenesis and high immunosuppression. AGFs produced by tumor and stromal cells can exert an immunomodulatory role in the glioma microenvironment by interacting with immune cells. This review aims to sum up the interactions among AGFs, immune cells and cancer cells with a particular emphasis on glioma and tries to provide new perspectives for understanding the glioma immune microenvironment and in-depth explorations for anti-glioma therapy.
引用
收藏
页数：13
相关论文
共 229 条
  • [11] Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
    Barrow, Alexander D.
    Edeling, Melissa A.
    Trifonov, Vladimir
    Luo, Jingqin
    Goyal, Piyush
    Bohl, Benjamin
    Bando, Jennifer K.
    Kim, Albert H.
    Walker, John
    Andahazy, Mary
    Bugatti, Mattia
    Melocchi, Laura
    Vermi, William
    Fremont, Daved H.
    Cox, Sarah
    Cella, Marina
    Schmedt, Christian
    Colonna, Marco
    [J]. CELL, 2018, 172 (03) : 534 - +
  • [12] Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
    Batchelor, Tracy T.
    Gerstner, Elizabeth R.
    Ye, Xiaobu
    Desideri, Serena
    Duda, Daniel G.
    Peereboom, David
    Lesser, Glenn J.
    Chowdhary, Sajeel
    Wen, Patrick Y.
    Grossman, Stuart
    Supko, Jeffrey G.
    [J]. NEURO-ONCOLOGY, 2017, 19 (04) : 567 - 575
  • [13] Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1,-2, and-3 and co-receptors neuropilin-1 and-2 does not predict bevacizumab response in human astrocytomas
    Baumgarten, Peter
    Blank, Anna-Eva
    Franz, Kea
    Hattingen, Elke
    Dunst, Maika
    Zeiner, Pia
    Hoffmann, Katharina
    Baehr, Oliver
    Maeder, Lisa
    Goeppert, Benjamin
    Machein, Marcia
    Seifert, Volker
    Steinbach, Joachim P.
    Plate, Karl H.
    Harter, Patrick N.
    Mittelbronn, Michel
    [J]. NEURO-ONCOLOGY, 2016, 18 (02) : 173 - 183
  • [14] The contribution of the peripheral immune system to neurodegeneration
    Berriat, Felix
    Lobsiger, Christian S.
    Boillee, Severine
    [J]. NATURE NEUROSCIENCE, 2023, 26 (06) : 942 - 954
  • [15] Challenges in glioblastoma research: focus on the tumor microenvironment
    Bikfalvi, Andreas
    da Costa, Cristine Alves
    Avril, Tony
    Barnier, Jean-Vianney
    Bauchet, Luc
    Brisson, Lucie
    Cartron, Pierre Francois
    Castel, Helene
    Chevet, Eric
    Chneiweiss, Herve
    Clavreul, Anne
    Constantin, Bruno
    Coronas, Valerie
    Daubon, Thomas
    Dontenwill, Monique
    Ducray, Francois
    Entz-Werle, Natacha
    Figarella-Branger, Dominique
    Fournier, Isabelle
    Frenel, Jean-Sebastien
    Gabut, Mathieu
    Galli, Thierry
    Gavard, Julie
    Huberfeld, Gilles
    Hugnot, Jean-Philippe
    Idbaih, Ahmed
    Junier, Marie-Pierre
    Mathivet, Thomas
    Menei, Philippe
    Meyronet, David
    Mirjolet, Celine
    Morin, Fabrice
    Mosser, Jean
    Moyal, Elisabeth Cohen-Jonathan
    Rousseau, Veronique
    Salzet, Michel
    Sanson, Marc
    Seano, Giorgio
    Tabouret, Emeline
    Tchoghandjian, Aurelie
    Turchi, Laurent
    Vallette, Francois M.
    Vats, Somya
    Verreault, Maite
    Virolle, Thierry
    [J]. TRENDS IN CANCER, 2023, 9 (01) : 9 - 27
  • [16] Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma
    Birch, Joanna L.
    Coull, Barry J.
    Spender, Lindsay C.
    Watt, Courtney
    Willison, Alice
    Syed, Nelofer
    Chalmers, Anthony J.
    Hossain-Ibrahim, M. Kismet
    Inman, Gareth J.
    [J]. CELLULAR SIGNALLING, 2020, 72
  • [17] Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
    Brar, Harpinder K.
    Jose, Jiney
    Wu, Zimei
    Sharma, Manisha
    [J]. PHARMACEUTICS, 2023, 15 (01)
  • [18] High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
    Bruna, Alejandra
    Darken, Rachel S.
    Rojo, Federico
    Ocana, Alberto
    Penuelas, Silvia
    Arias, Alexandra
    Paris, Raquel
    Tortosa, Avelina
    Mora, Jaume
    Baselga, Jose
    Seoane, Joan
    [J]. CANCER CELL, 2007, 11 (02) : 147 - 160
  • [19] Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
    Brunckhorst, Melissa K.
    Wang, Hui
    Lu, Rong
    Yu, Qin
    [J]. CANCER RESEARCH, 2010, 70 (18) : 7283 - 7293
  • [20] Glioma cell-derived FGF20 suppresses macrophage function by activating β-catenin
    Cai, Xue
    Tao, Weichen
    Li, Lei
    [J]. CELLULAR SIGNALLING, 2022, 89
12345678910